Author: Md. Mostaured Ali Khan; Md Nuruzzaman Khan; Md. Golam Mustagir; Juwel Rana; Md. Rajwanul Haque; Md. Mosfequr Rahman
Title: COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes Document date: 2020_4_3
ID: 0hrmk77p_40
Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.31.20049304 doi: medRxiv preprint mothers than their counterparts. These associations are unique, as the previous round of viral infection, such as SARS, did not find any evidence of the association between infection during pregnancy and occurrence of LBW and preterm birth [38] [39] [40] [41] . Viral infection affects pregnancy and fetal .....
Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.31.20049304 doi: medRxiv preprint mothers than their counterparts. These associations are unique, as the previous round of viral infection, such as SARS, did not find any evidence of the association between infection during pregnancy and occurrence of LBW and preterm birth [38] [39] [40] [41] . Viral infection affects pregnancy and fetal growth by gaining access to the placenta and decidua via hematogenous transmission or the lower reproductive tract, leading to the occurrence of such adverse outcomes [42] . However, effects can vary across cell types, gestational age, and changes in the uterine environment and maternal immunity [42] . Therefore, earlier preparedness of the healthcare sectors to handle these adverse consequences would be helpful to reduce further adverse outcomes, including maternal and perinatal mortality.
Search related documents:
Co phrase search for related documents- adverse outcome and fetal growth: 1, 2
- adverse outcome and gestational age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- adverse outcome and maternal immunity: 1
- adverse outcome and occurrence pregnancy: 1
- adverse outcome and perinatal maternal mortality: 1
- adverse outcome and preterm birth: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- adverse outcome and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cell type and fetal growth: 1
- cell type and gestational age: 1
- cell type and lower reproductive tract: 1
- cell type and previous round: 1
- cell type and reproductive tract: 1, 2, 3
- cell type and uterine environment: 1
- cell type and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- fetal growth and gestational age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- fetal growth and maternal immunity: 1
- fetal growth and preterm birth: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
Co phrase search for related documents, hyperlinks ordered by date